Pharmaceutical developer and manufacturer Boehringer Ingelheim has announced a $57 million expansion to its Animal Health Global Innovation Center in Athens. The facility, which will create more than 50 R&D jobs, will boost the company’s animal vaccine research and manufacturing program. Boehringer, based out of Germany, also has its U.S. HQ in Duluth and a poultry vaccine-manufacturing plant in Gainesville. The company says it was drawn to Georgia by its strong workforce, particularly from its University System (and in this case UGA’s lauded animal science program).
If you have something from your neck of the woods you’d like to see featured, please send it to phickey@insideradvantage.com
